# The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

> **NCT00315874** · PHASE3 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 225 (—)

## Conditions studied

- Back Pain

## Interventions

- **DRUG:** Buprenorphine transdermal delivery system

## Key facts

- **NCT ID:** NCT00315874
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** —
- **Final completion:** 1998-01
- **Target enrollment:** 225 (—)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315874, "The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00315874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*